Federal Official Gazette
DECISION OF MAY 20, 2026
To authorize the extension of the deadline for submitting contributions to Public Consultation No. 170, of March 23, 2026, by 45 (forty-five) days, counting from May 20, 2026, so as to extend the final period for public participation to Jul 3, 2026, for receiving contributions from civil society and regulated agents on the proposal to unify and update the rules for entering into contracts between operators and health service providers, replacing Normative Resolutions No. 503, of March 30, 2022, and No. 512, of March 31, 2022.
ANS news
ANS opens registration for the 3rd edition of the Projeto Cuidado Integral à Saúde
The National Supplementary Health Agency (ANS) on this Friday, May 15, launches the call for registrations for the 3rd edition of the Projeto Cuidado Integral à Saúde (Comprehensive Health Care Project). The initiative will select voluntary medical-hospital health plan operators to take part in an 18-month collaborative, in which they will receive support to develop, test and co-create the implementation of the Network Coordinated Care Model (Modelo de Atenção Coordenado em Rede), structured on the attributes of Primary Health Care (APS).
Cosaúde holds 51st technical meeting
The meeting will be held on May 26. See the schedule:
Day May 26, 2026
9:30 a.m. – Discussion of the proposals to update the List of Health Procedures and Events (Rol), on the following topics:
SHIFT
TECHNOLOGY
INDICATION FOR USE
9:30 a.m. to 12 p.m.
UAT 184 – Amendment of DUT 110 – Molecular DNA analysis – Subitem 110.39 – Syndromes of submicroscopic chromosomal abnormalities not clinically recognizable (Array and Exome).
(Preliminary discussion)
Diagnosis of patients with intellectual disability of undetermined cause.
2 p.m. to 5 p.m.
UAT 183 – Evolocumab
(Analysis of Public Participation)
Treatment of high cholesterol in adults who have suffered a recent serious cardiac event and are outside the LDL-c target, being considered high cardiovascular risk patients.
UAT 196 – Acalabrutinib in combination with Venetoclax
(Analysis of Public Participation)
Treatment of patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have not received prior treatment, and without deletion (17p) or TP53 mutation.
Open public consultations
- CP 172. Aims to receive contributions related to the proposals to update the List of Health Procedures and Events (Rol). Deadline:, May 13, 2026 to Jun 2, 2026.
- CP 170. Update of the regulation of the relationship between private health care plan operators and health care service providers. Deadline: Apr 1, 2026 to Jul 3, 2026.
Scheduled public hearings
- New: AP 66. Collection of contributions on the preliminary recommendation against incorporation for the following technologies: UAT 188 – Bimekizumab for the treatment of moderate to severe active hidradenitis suppurativa in adults who failed, were intolerant to or had a contraindication to systemic antibiotic therapy; and UAT 198 – Capivasertib for the treatment of locally advanced or metastatic breast cancer, HR+ and HER2-, with one or more alterations in PIK3CA/AKT1/PTEN. Date: May 22, 2026, from 9:30 a.m. to 12:30 p.m.
Open public calls for input
There is no open public call for input.
Open public calls
No updates.
Other news
ANS will schedule public hearing to discuss revision of portability rules
Source: jota.info · read the full article
Sources: Federal Official Gazette (DOU) and the ANS website. Press items link to the original article. This brief is for information only and does not constitute legal advice.